Reduced FRG1 expression promotes angiogenesis via activation of the FGF2‐mediated ERK/AKT pathway

Identifying novel targets that control both tumorigenesis and angiogenesis can aid in developing a more potent anti‐angiogenic therapeutic strategy. We previously reported that reduction of FRG1 is associated with increased p38‐MAPK signaling in prostate cancer and with elevated MEK–ERK signaling in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Bratati, Brahma, Pratush, Mohapatra, Talina, Chawla, Saurabh, Dixit, Manjusha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153342/
https://www.ncbi.nlm.nih.gov/pubmed/36815234
http://dx.doi.org/10.1002/2211-5463.13582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153342/
https://www.ncbi.nlm.nih.gov/pubmed/36815234
http://dx.doi.org/10.1002/2211-5463.13582

Ejemplares similares